3M (NYSE: MMM) has completed the sale of its Asia-Pacific pharmaceutical operations to Ironbridge Capital and Archer Capital (both of < ?XML:NAMESPACE PREFIX = ST1 />Australia) for $349 million. www.3m.com
3M (NYSE: MMM) has completed the sale of its Asia-Pacific pharmaceutical operations to Ironbridge Capital and Archer Capital (both of < ?XML:NAMESPACE PREFIX = ST1 />Australia) for $349 million. www.3m.com
Copyright PEI Media
Not for publication, email or dissemination